BMS-986458
BMS-986458 is a highly selective and orally active BCL6 PROTAC degrader. BMS-986458 simultaneously co-opts cereblon (CRBN) and the BCL6 N-terminal BTB domain to catalyze proximity induced degradation of BCL6. BMS-986458 can be used for the study of B-cell Non-Hodgkin's lymphoma (Pink: Target protein ligand ; Black: linker (HY-W267161) ; Blue: E3 ligase ligand (HY-W593794) ).
Product Specifications
CAS Number
3005272-36-3
UNSPSC
12352005
Target
BCL6; PROTACs
Related Pathways
Immunology/Inflammation; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H]1CN(CC[C@H]1NC2=CC=C3C(N(N=C3C4CCC(NC4=O)=O)C)=C2)C5=NC=C(C(NC6=CC7=C(N(C(C7)=O)C)C=C6)=N5)Cl
Molecular Formula
C32H34ClN9O3
Molecular Weight
628.12
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Cereblon
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![2-[3- (4-Bromophenyl) -1-[ (tert-butoxy) carbonyl]azetidin-3-yl]acetic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
2-[3- (4-Bromophenyl) -1-[ (tert-butoxy) carbonyl]azetidin-3-yl]acetic acid
2-[3- (4-Bromophenyl) -1-[ (tert-butoxy) carbonyl]azetidin-3-yl]acetic acid